pe
pep-05163 v1 CC-BY-SA-4.0

ANP metabolic peptide

A lab-stage peptide designed to switch on the body's blood-sugar and appetite control system, the same pathway used by Ozempic-style drugs. Not an approved medicine.

statuscomputed targetGLP-1R length30 aa refs1
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.717
pTM0.789
avg pLDDT69.5
ranking score0.700
STRUCTURE · PEP-05163 × GLP-1R
ranking0.700
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence30 aa
151015202530
NPMYNAVSNADLMDF KNLLDHLEEKMPLED
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.7170706987380981 boltz-2
ranking score 0.6996394991874695 boltz-2
structural qualityopenfold3
metricvaluenote
gpde1.040global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys-Asn-Leu-Leu-Asp-His-Leu-Glu-Glu-Lys-Met-Pro-Leu-Glu-Asp
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). ANP metabolic peptide (pep-05163, v1). PeptideModel. https://peptidemodel.com/card/pep-05163
@peptide{pep05163,
  sequence = {NPMYNAVSNADLMDFKNLLDHLEEKMPLED},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 1 by signal overlap
references 1 papers
[1] supporting
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use